Kiniksa Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Kiniksa Pharmaceuticals (KNSA) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Kiniksa Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Kiniksa Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Kiniksa Pharmaceuticals by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $1.5M | 85k | 17.53 |
2023-09-30 | $1.1M | 63k | 17.00 |
2023-06-30 | $628k | 45k | 14.08 |
2023-03-31 | $552k | 51k | 10.75 |
2022-12-31 | $856k | 57k | 14.98 |
2022-03-31 | $12k | 1.2k | 10.23 |
2021-12-31 | $901k | 77k | 11.77 |
2021-09-30 | $942k | 83k | 11.39 |
2021-06-30 | $279k | 20k | 13.94 |
2021-03-31 | $660k | 36k | 18.52 |
2020-12-31 | $24k | 1.4k | 17.56 |
2020-09-30 | $38k | 2.5k | 15.14 |
2020-06-30 | $271k | 11k | 25.44 |
2020-03-31 | $112k | 7.2k | 15.53 |
2019-12-31 | $210k | 19k | 11.07 |
2019-09-30 | $80k | 9.4k | 8.54 |
2019-06-30 | $23k | 1.7k | 13.26 |
2018-09-30 | $39k | 1.5k | 25.49 |